AM-Pharma B.V.: AM-Pharma Announces Publication of In Vivo Acute Kidney Injury Study Demonstrating Ilofotase Alfa's Dual Protective Mechanism
Study shows ilofotase alfa protects against ischemia-reperfusion induced acute kidney injury in rodents through the activation of adenosine receptors and the metabolism of extracellular adenosine
Kostenloser Wertpapierhandel Maarten Kraan Gretchen Schweitzer Trophic Communications Chief Medical Officer
Source: finanznachrichten.de